Physician profile
Barry Jay Goldsmith
NPI 1477536696
$783.13
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $146 · 2021: $197 · 2022: $119.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $214.76 | 2019-2022 | |
| Novo Nordisk INC | $158.64 | 2019-2022 | |
| Pfizer INC. | $59.88 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.51 | 2019-2020 | |
| Duchesnay USA Incorporated | $49.68 | 2019 | |
| Mayne Pharma Commercial LLC | $37.16 | 2021 | |
| Allergan, INC. | $36.96 | 2019 | |
| Exeltis, USA INC. | $31.32 | 2021-2022 | |
| Therapeuticsmd, INC. | $27.78 | 2019-2021 | |
| Myovant Sciences INC. | $20.25 | 2022 | |
| Amgen INC. | $18.91 | 2019 | |
| Hologic Sales and Service, LLC | $18.67 | 2022 | |
| Lupin INC. | $15.83 | 2020 | |
| Avion Pharmaceuticals | $14.66 | 2022 | |
| Millicent US INC | $12.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $11.20 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.